Gastric Ulcer
📧 Sign up to get email alerts when something new happens for Gastric Ulcer.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2025-03-31FDA Approved: PANTOPRAZOLE SODIUM DELAYED-RELEASE DELAYED RELEASE — Original Application (Cipla USA Inc.)
FDA approves Cipla USA Inc.'s pantoprazole sodium delayed-release granules as an original generic pantoprazole product (ANDA 217458) for aci…
-
FDA approval · 2025-03-31FDA Approved: PANTOPRAZOLE SODIUM — Original Application (Alembic Pharmaceuticals Limited)
FDA approved Alembic Pharmaceuticals Limited's original application for pantoprazole sodium injection, adding a new generic injectable panto…
-
FDA approval · 2025-03-31FDA Approved: PANTOPRAZOLE SODIUM — Original Application (Aurobindo Pharma Limited)
FDA approved the original application for Pantoprazole Sodium from Aurobindo Pharma Limited, making a generic pantoprazole available. The pr…
-
FDA approval · 2025-03-05FDA Approved: ESOMEPRAZOLE MAGNESIUM FOR DELAYED-RELEASE ORAL SUSPENSION — Original Application (Torrent Pharmaceuticals Limited)
FDA approved Torrent Pharmaceuticals Limited's esomeprazole magnesium for delayed-release oral suspension via an original ANDA, confirming b…
-
FDA approval · 2025-03-05FDA Approved: ESOMEPRAZOLE MAGNESIUM FOR DELAYED-RELEASE ORAL SUSPENSION — Original Application (Torrent Pharmaceuticals Limited)
FDA approved Torrent Pharmaceuticals' esomeprazole magnesium delayed-release oral suspension via an original application, providing a generi…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2025-02-27FDA Approved: DICLOFENAC SODIUM/MISOPROSTOL DICLOFENAC-SODIUM-MISOPROSTOL — Supplemental Application (Micro Labs Limited)
FDA approved a supplemental application for Diclofenac Sodium/Misoprostol (Diclofenac-Sodium-Misoprostol) from Micro Labs Limited.
-
CLINICAL_TRIALS trial_result · 2025-02-19Clinical Trial Update: A Study to Evaluate the Effiacy and Safety of HIP0612 in Patients With Gastric Ulcer [Phase 3]
A Phase 3 trial evaluating HIP0612 for gastric ulcer has completed; the update does not provide study results.
-
FDA approval · 2025-01-16FDA Approved: PANTOPRAZOLE SODIUM — Original Application (Rising Pharma Holdings, Inc.)
The FDA approved the original abbreviated new drug application for pantoprazole sodium from Rising Pharma Holdings, enabling the generic pro…
-
FDA approval · 2024-12-19FDA Approved: LANSOPRAZOLE — Supplemental Application (Medcore LLC)
The FDA approved a supplemental application for lansoprazole from Medcore LLC, enabling a generic lansoprazole product to be marketed under …
-
FDA approval · 2024-12-19FDA Approved: LANSOPRAZOLE — Supplemental Application (NorthStar Rx LLC)
The FDA approved a supplemental application for lansoprazole submitted by NorthStar Rx LLC.
-
FDA approval · 2024-11-27FDA Approved: PANTOPRAZOLE SODIUM — Supplemental Application (Amneal Pharmaceuticals LLC)
FDA approved a supplemental application for pantoprazole sodium from Amneal Pharmaceuticals LLC, updating the approval for this generic prot…
-
FDA approval · 2024-11-13FDA Approved: SUCRALFATE — Original Application (Cosette Pharmaceuticals, Inc.)
FDA approves Cosette Pharmaceuticals' generic sucralfate under an original ANDA for short-term treatment and maintenance of duodenal ulcers …
-
FDA approval · 2024-11-12FDA Approved: ESOMEPRAZOLE MAGNESIUM — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for esomeprazole magnesium from Mylan Pharmaceuticals, enabling the generic product to be marketed w…
-
FDA approval · 2024-11-12FDA Approved: CIMETIDINE — Original Application (Aurobindo Pharma Limited)
FDA approves Aurobindo Pharma Limited's original application for cimetidine (generic cimetidine), authorizing its marketing as a generic H2 …
-
FDA approval · 2024-11-08FDA Approved: GOOD NEIGHBOR PHARMACY OMEPRAZOLE — Supplemental Application (Amerisource Bergen)
FDA approved a supplemental application for Good Neighbor Pharmacy Omeprazole (omeprazole) submitted by Amerisource Bergen.
-
FDA approval · 2024-11-08FDA Approved: ACID REDUCER — Supplemental Application (WALGREEN CO.)
FDA approves a supplemental application for ACID REDUCER (omeprazole) from Walgreens Co., under ANDA206877.
-
FDA approval · 2024-11-07FDA Approved: CIMETIDINE — Original Application (Bionpharma Inc.)
FDA approved Bionpharma Inc.'s Original Application for cimetidine, enabling the marketing of a generic H2 blocker. The action establishes a…
-
FDA approval · 2024-11-05FDA Approved: RABEPRAZOLE SODIUM — Supplemental Application (Amneal Pharmaceuticals LLC)
FDA approved a supplemental application for rabeprazole sodium (Amneal Pharmaceuticals LLC).
-
FDA approval · 2024-11-04FDA Approved: LANSOPRAZOLE — Original Application (Macleods Pharmaceuticals Limited)
FDA approved a generic version of lansoprazole via an Original Abbreviated New Drug Application for Macleods Pharmaceuticals Limited.
-
FDA approval · 2024-10-23FDA Approved: ESOMEPRAZOLE — Original Application (Macleods Pharmaceuticals Limited)
FDA approved Esomeprazole under an Original Application for Macleods' generic product, enabling generic market access.
-
CLINICAL_TRIALS trial_result · 2024-10-16Clinical Trial Update: Study to Evaluate the Bioequivalence of Vonopzan Tablet 20mg(Vonoprazan Fumarate) and Vocinti Tablet 20mg in Healthy Adult Subjects. [Phase 1]
A completed Phase 1 bioequivalence study comparing two 20 mg vonoprazan fumarate tablets (Vonopzan and Vocinti) in healthy adult subjects, i…
-
FDA label_change · 2024-09-16FDA Approved: LANSOPRAZOLE — Supplemental Application (Zydus Pharmaceuticals USA Inc.)
The FDA approved a supplemental application for lansoprazole from Zydus Pharmaceuticals USA Inc., resulting in updated labeling for the prod…
-
FDA approval · 2024-09-05FDA Approved: MISOPROSTOL — Supplemental Application (AvPAK)
The FDA approved a supplemental application for MISOPROSTOL filed by AvPAK.
-
CLINICAL_TRIALS trial_result · 2024-08-26Clinical Trial Update: Clinical Trial to Evaluate the Efficacy and Safety of JP-1366 in Patients With Gastric Ulcer [Phase 3]
Phase 3 clinical trial evaluating the efficacy and safety of JP-1366 for gastric ulcer has completed.
-
FDA approval · 2024-08-20FDA Approved: FAMOTIDINE — Supplemental Application (Baxter Healthcare Corporation)
FDA approved Baxter Healthcare Corporation's supplemental application for famotidine (ANDA075591), granting approval for the generic product…